CY1106919T1 - Μεθοδος για τη βελτιωση της σταθεροτητας μιας φαρμακευτικης συνθεσης - Google Patents
Μεθοδος για τη βελτιωση της σταθεροτητας μιας φαρμακευτικης συνθεσηςInfo
- Publication number
- CY1106919T1 CY1106919T1 CY20071101289T CY071101289T CY1106919T1 CY 1106919 T1 CY1106919 T1 CY 1106919T1 CY 20071101289 T CY20071101289 T CY 20071101289T CY 071101289 T CY071101289 T CY 071101289T CY 1106919 T1 CY1106919 T1 CY 1106919T1
- Authority
- CY
- Cyprus
- Prior art keywords
- stability
- improving
- medicinal composition
- composition
- stabilizing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/081—Gamma radiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/20—Gaseous substances, e.g. vapours
- A61L2/206—Ethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η παρούσα εφεύρεση περιγράφει ειδικότερα μία μέθοδο για την σταθεροποίηση μίας φαρμακευτικής σύνθεσης η οποία συνίσταται στο να έρχεται σε επαφή η εν λόγω σύνθεση με ένα πολυμερές υλικό, μέθοδος η οποία περιλαμβάνει ειδικότερα το βήμα της αποστείρωσης με οξείδιο του αιθυλενίου.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00128318 | 2000-12-22 | ||
EP01985427A EP1349580B2 (en) | 2000-12-22 | 2001-12-20 | Process to improve stability of a pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106919T1 true CY1106919T1 (el) | 2012-09-26 |
Family
ID=8170784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071101289T CY1106919T1 (el) | 2000-12-22 | 2007-10-08 | Μεθοδος για τη βελτιωση της σταθεροτητας μιας φαρμακευτικης συνθεσης |
Country Status (15)
Country | Link |
---|---|
US (4) | US20040063607A1 (el) |
EP (1) | EP1349580B2 (el) |
JP (1) | JP4125957B2 (el) |
CN (1) | CN100396334C (el) |
AR (1) | AR032381A1 (el) |
AT (1) | ATE367831T1 (el) |
BR (1) | BRPI0116332B8 (el) |
CA (1) | CA2431906A1 (el) |
CY (1) | CY1106919T1 (el) |
DE (1) | DE60129597T3 (el) |
DK (1) | DK1349580T4 (el) |
ES (1) | ES2287173T5 (el) |
PT (1) | PT1349580E (el) |
TW (1) | TW586946B (el) |
WO (1) | WO2002051452A1 (el) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2357551T3 (es) * | 2000-09-13 | 2011-04-27 | Santen Pharmaceutical Co., Ltd. | Colirio. |
JP4694773B2 (ja) * | 2003-06-06 | 2011-06-08 | ロート製薬株式会社 | 粘膜適用液状組成物 |
EP1666043B1 (en) * | 2003-07-31 | 2009-12-02 | Santen Pharmaceutical Co., Ltd. | Product containing prostaglandin |
US20080139648A1 (en) * | 2004-12-09 | 2008-06-12 | Santen Pharmaceutical Co., Ltd. | Product Containing Prostaglandin Having Fluorine Atom In Its Molecule |
WO2006068266A1 (ja) * | 2004-12-24 | 2006-06-29 | Santen Pharmaceutical Co., Ltd. | プロスタグランジンF2a誘導体含有製品 |
US20060140820A1 (en) | 2004-12-28 | 2006-06-29 | Udo Mattern | Use of a container of an inorganic additive containing plastic material |
AR059927A1 (es) * | 2006-03-17 | 2008-05-07 | Johnson & Johnson Vision Care | Metodos para la estabilizacion de composiciones inestables a la oxidacion y composiciones oftalmicas estabilizadas |
WO2008040488A1 (en) | 2006-10-04 | 2008-04-10 | M & P Patent Aktiengesellschaft | Controlled release delivery system for nasal application of neurotransmitters |
EP2127638A1 (en) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
US20100216877A1 (en) * | 2009-02-20 | 2010-08-26 | Micro Labs Limited | Storage Stable Prostaglandin Product |
US8299079B2 (en) | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
EP2269575A1 (en) | 2009-06-30 | 2011-01-05 | Santen Pharmaceutical Co., Ltd | Method for improving bioavailability of latanoprost |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
AR086400A1 (es) | 2011-05-13 | 2013-12-11 | Trimel Pharmaceuticals Corp | Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo |
AU2013249034B2 (en) * | 2012-04-19 | 2016-04-28 | C. R. Bard, Inc. | Infusates with enhanced pH stability under ethylene oxide sterilization |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
JP6427843B2 (ja) | 2013-03-29 | 2018-11-28 | 株式会社AskAt | 眼疾患治療剤 |
JP7037349B2 (ja) * | 2017-06-23 | 2022-03-16 | 参天製薬株式会社 | 水溶性粘稠化剤を含有する医薬組成物 |
WO2018235935A1 (ja) * | 2017-06-23 | 2018-12-27 | 参天製薬株式会社 | 水溶性粘稠化剤を含有する医薬組成物 |
JPWO2019026992A1 (ja) * | 2017-08-03 | 2020-06-18 | 参天製薬株式会社 | クロルヘキシジンを含有する医薬組成物 |
BR112022024553A2 (pt) | 2020-07-16 | 2023-01-24 | Raqualia Pharma Inc | Composto com atividade inibidora de trpv4 ou um sal farmaceuticamente aceitável do mesmo e seu uso, composição farmacêutica, método para se tratar uma doença da retina acompanhada de distúrbio do fluxo sanguíneo ou distúrbio celular, kit para uso na prevenção ou tratamento das doenças, marcador de doença para uma doença da retina, método para se detectar uma doença da retina, métodos de triagem para uma substância que suprime a expressão do gene de trpv4, uma que reduz o nível de expressão de uma proteína de trpv4 e uma que inibe a atividade de trpv4 e agente para prevenir ou tratar uma doença da retina |
WO2022197633A1 (en) * | 2021-03-16 | 2022-09-22 | Vyluma Inc. | Multi-dose container for ophthalmic compositions |
US12233049B2 (en) * | 2021-11-15 | 2025-02-25 | Slayback Pharma Llc | Stable pharmaceutical compositions of clonidine |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE523577A (el) * | 1952-10-16 | |||
GB1107600A (en) † | 1965-12-15 | 1968-03-27 | U M P Venesta Ltd | Improvements relating to collapsible tubular containers |
CH483963A (fr) * | 1968-01-11 | 1970-01-15 | U M P Venesta Ltd | Récipient tubulaire souple |
NL7009539A (el) * | 1969-07-07 | 1971-01-11 | ||
US3728839A (en) * | 1971-04-29 | 1973-04-24 | American Cyanamid Co | Storage stable surgically absorbable polyglycolic acid products |
US4482585A (en) * | 1982-06-11 | 1984-11-13 | Toppan Printing Co., Ltd. | Container resistant to extremely low temperatures |
US5382406A (en) * | 1990-04-17 | 1995-01-17 | Abbott Laboratories | Sterile filling method |
JP3256997B2 (ja) † | 1990-08-30 | 2002-02-18 | 千寿製薬株式会社 | 安定な水性製剤 |
US5620425A (en) * | 1993-11-03 | 1997-04-15 | Bracco International B.V. | Method for the preparation of pre-filled plastic syringes |
US5749203A (en) * | 1994-09-23 | 1998-05-12 | Kimberly-Clark Corporation | Method of packaging a medical article |
SE515221C2 (sv) * | 1996-03-20 | 2001-07-02 | Scandimed Internat Ab | Förfarande för framställning av och anordning vid en förpackning med en sterilt förpackad behållare med sterilt innehåll |
US6132679A (en) * | 1997-12-24 | 2000-10-17 | Alliedsignal, Inc. | Method and apparatus for aerating chemically-sterilized articles |
AU2042200A (en) * | 1998-12-07 | 2000-06-26 | Baylor College Of Medicine | Preventing and removing biofilm from the surface of medical devices |
US6440364B1 (en) * | 1999-02-16 | 2002-08-27 | Ethicon, Inc. | Method of degassing absorbable suture products |
US6231810B1 (en) * | 1999-04-21 | 2001-05-15 | Stryker Technologies Corporation | Special cycle for ethylene oxide sterilization |
EE04459B1 (et) * | 1999-05-28 | 2005-04-15 | Novartis Ag | Meetod farmatseutilisele tootele mõeldud steriliseeritud kokkupigistatava pakendi valmistamiseks |
-
2001
- 2001-12-13 TW TW090130924A patent/TW586946B/zh not_active IP Right Cessation
- 2001-12-20 AT AT01985427T patent/ATE367831T1/de active
- 2001-12-20 PT PT01985427T patent/PT1349580E/pt unknown
- 2001-12-20 CN CNB01821021XA patent/CN100396334C/zh not_active Expired - Lifetime
- 2001-12-20 DK DK01985427.2T patent/DK1349580T4/da active
- 2001-12-20 EP EP01985427A patent/EP1349580B2/en not_active Expired - Lifetime
- 2001-12-20 WO PCT/EP2001/015126 patent/WO2002051452A1/en active IP Right Grant
- 2001-12-20 ES ES01985427T patent/ES2287173T5/es not_active Expired - Lifetime
- 2001-12-20 US US10/451,088 patent/US20040063607A1/en not_active Abandoned
- 2001-12-20 JP JP2002552593A patent/JP4125957B2/ja not_active Expired - Fee Related
- 2001-12-20 BR BRPI0116332A patent/BRPI0116332B8/pt not_active IP Right Cessation
- 2001-12-20 DE DE60129597T patent/DE60129597T3/de not_active Expired - Lifetime
- 2001-12-20 CA CA002431906A patent/CA2431906A1/en not_active Abandoned
- 2001-12-20 AR ARP010105949A patent/AR032381A1/es unknown
-
2007
- 2007-10-08 CY CY20071101289T patent/CY1106919T1/el unknown
-
2008
- 2008-01-18 US US12/016,428 patent/US20080300277A1/en not_active Abandoned
-
2011
- 2011-03-29 US US13/074,183 patent/US20110173928A1/en not_active Abandoned
-
2012
- 2012-12-14 US US13/714,631 patent/US20130097969A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040063607A1 (en) | 2004-04-01 |
US20110173928A1 (en) | 2011-07-21 |
ES2287173T3 (es) | 2007-12-16 |
TW586946B (en) | 2004-05-11 |
EP1349580B1 (en) | 2007-07-25 |
AR032381A1 (es) | 2003-11-05 |
DK1349580T3 (da) | 2007-10-01 |
DE60129597T3 (de) | 2012-11-29 |
ES2287173T5 (es) | 2012-10-03 |
BRPI0116332B8 (pt) | 2021-06-22 |
CA2431906A1 (en) | 2002-07-04 |
US20080300277A1 (en) | 2008-12-04 |
JP2004516099A (ja) | 2004-06-03 |
EP1349580B2 (en) | 2012-07-04 |
BR0116332A (pt) | 2004-03-02 |
JP4125957B2 (ja) | 2008-07-30 |
EP1349580A1 (en) | 2003-10-08 |
BR0116332B1 (pt) | 2014-08-19 |
DK1349580T4 (da) | 2012-10-08 |
WO2002051452A1 (en) | 2002-07-04 |
CN100396334C (zh) | 2008-06-25 |
PT1349580E (pt) | 2007-10-25 |
CN1481259A (zh) | 2004-03-10 |
DE60129597T2 (de) | 2008-04-17 |
DE60129597D1 (de) | 2007-09-06 |
US20130097969A1 (en) | 2013-04-25 |
ATE367831T1 (de) | 2007-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106919T1 (el) | Μεθοδος για τη βελτιωση της σταθεροτητας μιας φαρμακευτικης συνθεσης | |
CY1107841T1 (el) | Φαρμακευτικα σκευασματα τα οποια περιλαμβανουν μυκοφαινολικο οξυ ή μυκοφαινολικο αλας | |
CY1106532T1 (el) | Ετερολογος εκφραση των πρωτεϊνων της neisseria | |
NO20005224L (no) | BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse | |
CY1116023T1 (el) | Μορφες φαρμακευτικης δοσολογιας παρατεταμενης απελευθερωσης με περιγραμματα διαλυτοποιησης ελαχιστοποιημενης εξαρτησης απο το ph | |
ATE553780T1 (de) | Ph-sensitives polymer | |
BR0210335A (pt) | Copolìmero de blocos, e, composição | |
CY1116855T1 (el) | Μεθοδοι για την παρασκευη κυτταροτοξικων συζευγματων μεϋτανσινοειδων και παραγοντων δεσμευσης κυτταρων | |
DE60331458D1 (de) | Kombinationschemotherapie mit chlorotoxin | |
CY1105051T1 (el) | Παρασκευασμα σε μορφη υμενιου για τη διφασικη απελευθερωση ουσιων με φαρμακολογικη δραση ή αλλων ουσιων | |
CY1111613T1 (el) | Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv | |
DE60307988D1 (de) | Medizinisches gerät | |
DE60007095D1 (de) | Calanolide zur hemmung von btk | |
CY1107294T1 (el) | Τοπικη συνθεση η οποια περιεχει τουλαχιστον μια βιταμινη d ή ενα αναλογο της βιταμινης d και τουλαχιστον ενα κορτικοστεροειδες | |
CY1113312T1 (el) | Κυκλικοι αναστολεις κινασης τυροσινης πρωτεϊνων | |
NO20074807L (no) | Fast farmasoytisk doseringsformulering | |
NO20024891D0 (no) | Farmasöytiske sammensetninger | |
CY1107911T1 (el) | Διαταξη αφαιρεσεως | |
CY1105247T1 (el) | Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης | |
CY1107759T1 (el) | Λυοφιλισμενη συνταγοποιηση που περιλαμβανει ολανζαπινη | |
BR0114241B1 (pt) | composição para desinfetar uma lente de contato, e método para desinfetar uma lente de contato. | |
CY1105442T1 (el) | Μικροσωματιδια με βελτιωμενο πepιγραμμα απελευθερωσης και μεθοδος για την παραγωγη τους | |
CY1109221T1 (el) | Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum | |
CY1114614T1 (el) | Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα | |
CY1105980T1 (el) | Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου |